• Kane Biotech entered a non-exclusive Canadian distribution agreement with Ontario Medical Supply, expanding commercial reach in wound care.
• Ontario Medical Supply will buy, market, support revyve Antimicrobial Wound Gel, revyve Antimicrobial Wound Gel Spray, both FDA 510(k) cleared.
• Deal targets Ontario Health atHome access, where Ontario Medical Supply is one of two authorized distributors and price agreement holders.
• Ontario Health atHome served more than 680,000 patients annually, delivered 11.1 million nursing visits in 2024-25.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kane Biotech Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609020705PRIMZONEFULLFEED9819786) on September 02, 2026, and is solely responsible for the information contained therein.